The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

TitleEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Publication TypeJournal Article
Year of Publication2016
AuthorsSarafidis, P. A., & Tsapas A.
JournalN Engl J Med
Volume374
Issue11
Pagination1092
Date Published2016 03 17
ISSN1533-4406
KeywordsBenzhydryl Compounds, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Glucosides, Humans, Hypoglycemic Agents, Male
DOI10.1056/NEJMc1600827
Alternate JournalN. Engl. J. Med.
PubMed ID26981941

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.